Abstract
The inefficient delivery of genes to target tissues and the inability to monitor delivery of genes and therapeutic responses at both cellular and tissue level hinder the success of gene therapy. Fortunately, molecular imaging strategy provides a vital role in assisting gene therapy in a noninvasive and spatiotemporal manner. To better optimize the effectiveness of gene therapy, numerous functional nanoparticles have been developed to achieve this goal while visualizing the delivery process. This chapter provides an overview of various functionalized nanoparticles with unique physiochemical properties for molecular imaging-guided gene therapy.
The original version of this chapter was revised: The name and affiliation of the author Yu Zhang was corrected. The erratum to this chapter is available at: http://dx.doi.org/10.1007/978-981-10-0063-8_11
An erratum to this chapter can be found at http://dx.doi.org/10.1007/978-981-10-0063-8_11
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ginn SL, Alexander IE, Edelstein ML, Abedi MR, Wixon J (2013) Gene therapy clinical trials worldwide to 2012 – an update. J Gene Med 15(2):65–77. doi:10.1002/jgm.2698
Liu G, Swierczewska M, Lee S, Chen X (2010) Functional nanoparticles for molecular imaging guided gene delivery. Nano Today 5(6):524–539. doi:10.1016/j.nantod.2010.10.005
Castellani S, Conese M (2010) Lentiviral vectors and cystic fibrosis gene therapy. Viruses 2(2):395–412
Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS, Cideciyan AV, Pearce-Kelling SE, Anand V, Zeng Y, Maguire AM (2001) Gene therapy restores vision in a canine model of childhood blindness. Nat Genet 28(1):92–95
Allen PJ, Feigin A (2014) Gene-based therapies in Parkinson’s disease. Neurotherapeutics 11(1):60–67
Cross D, Burmester JK (2006) Gene therapy for cancer treatment: past, present and future. Clin Med Res 4(3):218–227
Whitehead KA, Langer R, Anderson DG (2009) Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 8(2):129–138
Wang J, Lu Z, Wientjes MG, Au JL (2010) Delivery of siRNA therapeutics: barriers and carriers. AAPS J 12(4):492–503. doi:10.1208/s12248-010-9210-4
Liu X-Q, Sun C-Y, Yang X-Z, Wang J (2013) Polymeric-micelle-based nanomedicine for siRNA delivery. Part Part Syst Char 30(3):211–228. doi:10.1002/ppsc.201200061
Oh Y-K, Park TG (2009) siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev 61(10):850–862
Bumcrot D, Manoharan M, Koteliansky V, Sah DW (2006) RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol 2(12):711–719
Kanasty R, Dorkin JR, Vegas A, Anderson D (2013) Delivery materials for siRNA therapeutics. Nat Mater 12(11):967–977
Wang Z, Liu G, Zheng H, Chen X (2014) Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities. Biotechnol Adv 32(4):831–843. doi:10.1016/j.biotechadv.2013.08.020
Zaidi SK, Young DW, Javed A, Pratap J, Montecino M, van Wijnen A, Lian JB, Stein JL, Stein GS (2007) Nuclear microenvironments in biological control and cancer. Nat Rev Cancer 7(6):454–463
Jones CH, Chen C-K, Ravikrishnan A, Rane S, Pfeifer BA (2013) Overcoming nonviral gene delivery barriers: perspective and future. Mol Pharm 10(11):4082–4098. doi:10.1021/mp400467x
James ML, Gambhir SS (2012) A molecular imaging primer: modalities, imaging agents, and applications. Physiol Rev 92(2):897–965. doi:10.1152/physrev.00049.2010
Kango S, Kalia S, Celli A, Njuguna J, Habibi Y, Kumar R (2013) Surface modification of inorganic nanoparticles for development of organic–inorganic nanocomposites – a review. Prog Polym Sci 38(8):1232–1261. doi:10.1016/j.progpolymsci.2013.02.003
Kaittanis C, Shaffer TM, Thorek DL, Grimm J (2014) Dawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy. Crit Rev Oncog 19(3–4):143–176
Hu TY (2014) Multidisciplinary efforts driving translational theranostics. Theranostics 4(12):1209–1210
Niu G, Chen X (2009) Noninvasive visualization of microRNA by bioluminescence imaging. Mol Imaging Biol 11(2):61–63. doi:10.1007/s11307-008-0190-z
Na HB, Song IC, Hyeon T (2009) Inorganic nanoparticles for MRI contrast agents. Adv Mater 21(21):2133–2148. doi:10.1002/adma.200802366
Bao G, Mitragotri S, Tong S (2013) Multifunctional nanoparticles for drug delivery and molecular imaging. Annu Rev Biomed Eng 15:253–282. doi:10.1146/annurev-bioeng-071812-152409
Strijkers GJ, Mulder WJ, van Tilborg GA, Nicolay K (2007) MRI contrast agents: current status and future perspectives. Anticancer Agents Med Chem 7(3):291–305
Zhu D, Liu F, Ma L, Liu D, Wang Z (2013) Nanoparticle-based systems for t1-weighted magnetic resonance imaging contrast agents. Int J Mol Sci 14(5):10591–10607. doi:10.3390/ijms140510591
Ratzinger G, Agrawal P, Korner W, Lonkai J, Sanders HM, Terreno E, Wirth M, Strijkers GJ, Nicolay K, Gabor F (2010) Surface modification of PLGA nanospheres with Gd-DTPA and Gd-DOTA for high-relaxivity MRI contrast agents. Biomaterials 31(33):8716–8723. doi:10.1016/j.biomaterials.2010.07.095
Su H, Wu C, Zhu J, Miao T, Wang D, Xia C, Zhao X, Gong Q, Song B, Ai H (2012) Rigid Mn(ii) chelate as efficient MRI contrast agent for vascular imaging. Dalton Trans 41(48):14480–14483. doi:10.1039/C2DT31696J
Luo K, Tian J, Liu G, Sun J, Xia C, Tang H, Lin L, Miao T, Zhao X, Gao F, Gong Q, Song B, Shuai X, Ai H, Gu Z (2010) Self-assembly of SiO2/Gd-DTPA-polyethylenimine nanocomposites as magnetic resonance imaging probes. J Nanosci Nanotechnol 10(1):540–548
Sevick-Muraca EM (2012) Translation of near-infrared fluorescence imaging technologies: emerging clinical applications. Annu Rev Med 63:217–231. doi:10.1146/annurev-med-070910-083323
Larson DR, Ow H, Vishwasrao HD, Heikal AA, Wiesner U, Webb WW (2008) Silica nanoparticle architecture determines radiative properties of encapsulated fluorophores. Chem Mater 20(8):2677–2684. doi:10.1021/cm7026866
Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L (2003) A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res 63(23):8122–8125
Lee HY, Li Z, Chen K, Hsu AR, Xu C, Xie J, Sun S, Chen X (2008) PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. J Nucl Med 49(8):1371–1379. doi:10.2967/jnumed.108.051243
Mahmoudi M, Sant S, Wang B, Laurent S, Sen T (2011) Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev 63(1–2):24–46. doi:10.1016/j.addr.2010.05.006
Viglianti BL, Abraham SA, Michelich CR, Yarmolenko PS, MacFall JR, Bally MB, Dewhirst MW (2004) In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: illustration of targeted delivery. Magn Reson Med 51(6):1153–1162. doi:10.1002/mrm.20074
Turetschek K, Preda A, Floyd E, Shames D, Novikov V, Roberts T, Wood J, Fu Y, Carter W, Brasch R (2003) MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model. Eur J Nucl Med 30(3):448–455. doi:10.1007/s00259-002-1000-5
Shapiro B (2009) Towards dynamic control of magnetic fields to focus magnetic carriers to targets deep inside the body. J Magn Magn Mater 321(10):1594. doi:10.1016/j.jmmm.2009.02.094
Shim MS, Kwon YJ (2012) Stimuli-responsive polymers and nanomaterials for gene delivery and imaging applications. Adv Drug Deliv Rev 64(11):1046–1059. doi:10.1016/j.addr.2012.01.018
Lemkine GF, Demeneix BA (2001) Polyethylenimines for in vivo gene delivery. Curr Opin Mol Ther 3(2):178–182
Zhang X, Oulad-Abdelghani M, Zelkin AN, Wang Y, Haikel Y, Mainard D, Voegel JC, Caruso F, Benkirane-Jessel N (2010) Poly(L-lysine) nanostructured particles for gene delivery and hormone stimulation. Biomaterials 31(7):1699–1706. doi:10.1016/j.biomaterials.2009.11.032
Zhou J, Wu J, Hafdi N, Behr J-P, Erbacher P, Peng L (2006) PAMAM dendrimers for efficient siRNA delivery and potent gene silencing. Chem Commun 22:2362–2364. doi:10.1039/B601381C
McKenzie DL, Kwok KY, Rice KG (2000) A potent new class of reductively activated peptide gene delivery agents. J Biol Chem 275(14):9970–9977
Dachs GU, Dougherty GJ, Stratford IJ, Chaplin DJ (1997) Targeting gene therapy to cancer: a review. Oncol Res 9(6–7):313–325
Schiffelers RM, Ansari A, Xu J, Zhou Q, Tang Q, Storm G, Molema G, Lu PY, Scaria PV, Woodle MC (2004) Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res 32(19), e149, http://www.ncbi.nlm.nih.gov/pubmed/15520458
Low PS, Henne WA, Doorneweerd DD (2007) Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res 41(1):120–129
Brannon-Peppas L, Blanchette JO (2012) Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 64:206–212
Bagalkot V, Zhang L, Levy-Nissenbaum E, Jon S, Kantoff PW, Langer R, Farokhzad OC (2007) Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett 7(10):3065–3070
Matsumura Y, Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46(12 Pt 1):6387–6392
Fang J, Nakamura H, Maeda H (2011) The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 63(3):136–151. doi:10.1016/j.addr.2010.04.009
Kularatne SA, Low PS (2010) Targeting of nanoparticles: folate receptor. Methods Mol Biol (Clifton, NJ) 624:249–265. doi:10.1007/978-1-60761-609-2_17
Danhier F, Breton AL, Préat V (2012) RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. Mol Pharm 9(11):2961–2973. doi:10.1021/mp3002733
Vecchione L, Jacobs B, Normanno N, Ciardiello F, Tejpar S (2011) EGFR-targeted therapy. Exp Cell Res 317(19):2765–2771. doi:10.1016/j.yexcr.2011.08.021
Li Z, Zhao R, Wu X, Sun Y, Yao M, Li J, Xu Y, Gu J (2005) Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics. FASEB J 19(14):1978–1985. doi:10.1096/fj.05-4058com
Huang X, Peng X, Wang Y, Wang Y, Shin DM, El-Sayed MA, Nie S (2010) A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano 4(10):5887–5896. doi:10.1021/nn102055s
Chang SJ, Lee CH, Hsu CY, Wang YJ (2002) Biocompatible microcapsules with enhanced mechanical strength. J Biomed Mater Res 59:118–126
Miao T, Rao KS, Spees JL, Oldinski RA (2014) Osteogenic differentiation of human mesenchymal stem cells through alginate-graft-poly(ethylene glycol) microsphere-mediated intracellular growth factor delivery. J Control Release 192(0):57–66. doi:10.1016/j.jconrel.2014.06.029
Davidovich-Pinhas M, Bianco-Peled H (2011) Alginate-PEGAc: a new mucoadhesive polymer. Acta Biomater 7:625–633
Davidovich-Pinhas M, Bianco-Peled H (2011) Physical and structural characteristics of acrylated poly(ethylene glycol)-alginate conjugates. Acta Biomater 7:2817–2825
Meng X-W, Qin J, Liu Y, Fan M-M, Li B-J, Zhang S, Yu X-Q (2010) Degradable hollow spheres based on self-assembly inclusion. Chem Commun 46:643–645
Meng X-W, Ha W, Cheng C, Dong Z-Q, Ding L-S, Li B-J, Zhang S (2011) Hollow nanospheres based on the self-assembly of alginate-graft-poly(ethylene glycol) and α-cyclodextrin. Langmuir 27:14401–14407
Mahou R, Wandrey C (2010) Alginate-poly(ethylene glycol) hybrid microspheres with adjustable physical properties. Macromolecules (Washington, DC, US) 43(3):1371–1378. doi:10.1021/ma902469f
Mahou R, Tran NM, Dufresne M, Legallais C, Wandrey C (2012) Encapsulation of Huh-7 cells within alginate-poly(ethylene glycol) hybrid microspheres. J Mater Sci-Mater M 23(1):171–179. doi:10.1007/s10856-011-4512-3
Knop K, Hoogenboom R, Fischer D, Schubert US (2010) Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem Int Ed 49(36):6288–6308. doi:10.1002/anie.200902672
Bassyouni F, ElHalwany N, Abdel Rehim M, Neyfeh M (2013) Advances and new technologies applied in controlled drug delivery system. Res Chem Intermed:1–36. doi:10.1007/s11164-013-1338-2
Andresen TL, Thompson DH, Kaasgaard T (2010) Enzyme-triggered nanomedicine: drug release strategies in cancer therapy. Mol Membr Biol 27(7):353–363. doi:10.3109/09687688.2010.515950
Walker GF, Fella C, Pelisek J, Fahrmeir J, Boeckle S, Ogris M, Wagner E (2005) Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo. Mol Ther 11(3):418–425. doi:10.1016/j.ymthe.2004.11.006
Varkouhi AK, Scholte M, Storm G, Haisma HJ (2011) Endosomal escape pathways for delivery of biologicals. J Control Release 151(3):220–228. doi:10.1016/j.jconrel.2010.11.004
Huang HW, Chen F-Y, Lee M-T (2004) Molecular mechanism of peptide-induced pores in membranes. Phys Rev Lett 92(19):198304
Miller DK, Griffiths E, Lenard J, Firestone RA (1983) Cell killing by lysosomotropic detergents. J Cell Biol 97(6):1841–1851
Epand RM (2003) Fusion peptides and the mechanism of viral fusion. Biochim Biophys Acta 1614(1):116–121
Lou PJ, Lai PS, Shieh MJ, Macrobert AJ, Berg K, Bown SG (2006) Reversal of doxorubicin resistance in breast cancer cells by photochemical internalization. Int J Cancer 119(11):2692–2698. doi:10.1002/ijc.22098
Zeng Y, Cullen BR (2002) RNA interference in human cells is restricted to the cytoplasm. RNA 8(7):855–860
van der Aa MA, Mastrobattista E, Oosting RS, Hennink WE, Koning GA, Crommelin DJ (2006) The nuclear pore complex: the gateway to successful nonviral gene delivery. Pharm Res 23(3):447–459. doi:10.1007/s11095-005-9445-4
Zanta MA, Belguise-Valladier P, Behr JP (1999) Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc Natl Acad Sci U S A 96(1):91–96
Alexis F, Zeng J, Shu W (2006) PEI nanoparticles for targeted gene delivery. Cold Spring Harb Protoc 2006(1):pdb. prot4451
Koping-Hoggard M, Tubulekas I, Guan H, Edwards K, Nilsson M, Varum KM, Artursson P (2001) Chitosan as a nonviral gene delivery system. Structure–property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther 8(14):1108–1121. doi:10.1038/sj.gt.3301492
Saranya N, Moorthi A, Saravanan S, Devi MP, Selvamurugan N (2011) Chitosan and its derivatives for gene delivery. Int J Biol Macromol 48(2):234–238. doi:10.1016/j.ijbiomac.2010.11.013
Toncheva V, Wolfert MA, Dash PR, Oupicky D, Ulbrich K, Seymour LW, Schacht EH (1998) Novel vectors for gene delivery formed by self-assembly of DNA with poly (L-lysine) grafted with hydrophilic polymers. Biochim Biophys Acta 1380(3):354–368
Shcharbin D, Shakhbazau A, Bryszewska M (2013) Poly(amidoamine) dendrimer complexes as a platform for gene delivery. Expert Opin Drug Deliv 10(12):1687–1698. doi:10.1517/17425247.2013.853661
Benns JM, Choi JS, Mahato RI, Park JS, Kim SW (2000) pH-sensitive cationic polymer gene delivery vehicle: N-Ac-poly(L-histidine)-graft-poly(L-lysine) comb shaped polymer. Bioconjug Chem 11(5):637–645
Choi YH, Liu F, Kim J-S, Choi YK, Jong Sang P, Kim SW (1998) Polyethylene glycol-grafted poly-l-lysine as polymeric gene carrier. J Control Release 54(1):39–48. doi:10.1016/S0168-3659(97)00174-0
Moghimi SM, Hunter AC, Murray JC (2001) Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53(2):283–318
Jeong B, Gutowska A (2002) Lessons from nature: stimuli-responsive polymers and their biomedical applications. Trends Biotechnol 20(7):305–311
Juliano RL, Stamp D (1975) The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. Biochem Biophys Res Commun 63(3):651–658
Stolnik S, Illum L, Davis SS (2012) Long circulating microparticulate drug carriers. Adv Drug Deliv Rev 64(Suppl (0)):290–301. doi:10.1016/j.addr.2012.09.029
Beningo KA, Wang YL (2002) Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target. J Cell Sci 115(Pt 4):849–856
Kesharwani P, Jain K, Jain NK (2014) Dendrimer as nanocarrier for drug delivery. Prog Polym Sci 39(2):268–307. doi:10.1016/j.progpolymsci.2013.07.005
Svenson S, Tomalia DA (2005) Dendrimers in biomedical applications – reflections on the field. Adv Drug Deliv Rev 57(15):2106–2129. doi:10.1016/j.addr.2005.09.018
Lee CC, MacKay JA, Frechet JMJ, Szoka FC (2005) Designing dendrimers for biological applications. Nat Biotechnol 23(12):1517–1526. http://www.nature.com/nbt/journal/v23/n12/suppinfo/nbt1171_S1.html
Amirkhanov NV, Zhang K, Aruva MR, Thakur ML, Wickstrom E (2010) Imaging human pancreatic cancer xenografts by targeting mutant KRAS2 mRNA with [111In]DOTAn-Poly(diamidopropanoyl)m-KRAS2 PNA-d(Cys-Ser-Lys-Cys) nanoparticles. Bioconjug Chem 21(4):731–740. doi:10.1021/bc900523c
Lin Q, Chen J, Zhang Z, Zheng G (2014) Lipid-based nanoparticles in the systemic delivery of siRNA. Nanomedicine (Lond) 9(1):105–120. doi:10.2217/nnm.13.192
Miller AD (2013) Lipid-based nanoparticles in cancer diagnosis and therapy. J Drug Delivery 2013:9. doi:10.1155/2013/165981
Mulder WJ, Strijkers GJ, van Tilborg GA, Griffioen AW, Nicolay K (2006) Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed 19(1):142–164. doi:10.1002/nbm.1011
Gilleron J, Querbes W, Zeigerer A, Borodovsky A, Marsico G, Schubert U, Manygoats K, Seifert S, Andree C, Stoter M, Epstein-Barash H, Zhang L, Koteliansky V, Fitzgerald K, Fava E, Bickle M, Kalaidzidis Y, Akinc A, Maier M, Zerial M (2013) Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat Biotechnol 31(7):638–646. doi:10.1038/nbt.2612, http://www.nature.com/nbt/journal/v31/n7/abs/nbt.2612.html#supplementary-information
Jiang S, Eltoukhy AA, Love KT, Langer R, Anderson DG (2013) Lipidoid-coated iron oxide nanoparticles for efficient DNA and siRNA delivery. Nano Lett 13(3):1059–1064. doi:10.1021/nl304287a
Tatur S, Maccarini M, Barker R, Nelson A, Fragneto G (2013) Effect of functionalized gold nanoparticles on floating lipid bilayers. Langmuir 29(22):6606–6614. doi:10.1021/la401074y
Qiu L, Jing N, Jin Y (2008) Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method. Int J Pharm 361(1–2):56–63. doi:10.1016/j.ijpharm.2008.05.010
Malam Y, Loizidou M, Seifalian AM (2009) Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci 30(11):592–599. doi:10.1016/j.tips.2009.08.004
Pearce TR, Shroff K, Kokkoli E (2012) Peptide targeted lipid nanoparticles for anticancer drug delivery. Adv Mater (Deerfield Beach, Fla) 24(28):3803–3822, 3710. doi:10.1002/adma.201200832
Puri A, Loomis K, Smith B, Lee JH, Yavlovich A, Heldman E, Blumenthal R (2009) Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst 26(6):523–580
Barenholz Y (2012) Doxil® – the first FDA-approved nano-drug: lessons learned. J Control Release 160(2):117–134. doi:10.1016/j.jconrel.2012.03.020
Ogawara K, Un K, Tanaka K, Higaki K, Kimura T (2009) In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: involvement of cytotoxic effect on vascular endothelial cells. J Control Release 133(1):4–10. doi:10.1016/j.jconrel.2008.09.008
Krishnan K, Pakhomov A, Bao Y, Blomqvist P, Chun Y, Gonzales M, Griffin K, Ji X, Roberts B (2006) Nanomagnetism and spin electronics: materials, microstructure and novel properties. J Mater Sci 41(3):793–815
Lee J-H, Huh Y-M, Y-w J, J-w S, J-t J, Song H-T, Kim S, Cho E-J, Yoon H-G, Suh J-S (2006) Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 13(1):95–99
Lin C, Cai S, Feng J (2012) Positive contrast imaging of SPIO nanoparticles. J Nanomater 2012:9. doi:10.1155/2012/734842
Sadhukha T, Wiedmann TS, Panyam J (2013) Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy. Biomaterials 34(21):5163–5171. doi:10.1016/j.biomaterials.2013.03.061
Baraki H, Zinne N, Wedekind D, Meier M, Bleich A, Glage S, Hedrich HJ, Kutschka I, Haverich A (2012) Magnetic resonance imaging of soft tissue infection with iron oxide labeled granulocytes in a rat model. PLoS One 7(12), e51770. doi:10.1371/journal.pone.0051770
Patel D, Kell A, Simard B, Deng J, Xiang B, Lin H-Y, Gruwel M, Tian G (2010) Cu2+−labeled, SPION loaded porous silica nanoparticles for cell labeling and multifunctional imaging probes. Biomaterials 31(10):2866–2873
Liu G, Xie J, Zhang F, Wang Z, Luo K, Zhu L, Quan Q, Niu G, Lee S, Ai H, Chen X (2011) N-Alkyl-PEI-functionalized iron oxide nanoclusters for efficient siRNA delivery. Small 7(19):2742–2749. doi:10.1002/smll.201100825
Ai H, Flask C, Weinberg B, Shuai XT, Pagel MD, Farrell D, Duerk J, Gao J (2005) Magnetite-loaded polymeric micelles as ultrasensitive magnetic-resonance probes. Adv Mater 17(16):1949–1952. doi:10.1002/adma.200401904
Sun S, Zeng H, Robinson DB, Raoux S, Rice PM, Wang SX, Li G (2003) Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc 126(1):273–279. doi:10.1021/ja0380852
Clement O, Siauve N, Cuenod CA, Frija G (1998) Liver imaging with ferumoxides (Feridex): fundamentals, controversies, and practical aspects. Top Magn Reson Imaging 9(3):167–182
del Pino P, Munoz-Javier A, Vlaskou D, Rivera Gil P, Plank C, Parak WJ (2010) Gene silencing mediated by magnetic lipospheres tagged with small interfering RNA. Nano Lett 10(10):3914–3921. doi:10.1021/nl102485v
Zhang C, Gao S, Jiang W, Lin S, Du F, Li Z, Huang W (2010) Targeted minicircle DNA delivery using folate–poly(ethylene glycol)–polyethylenimine as non-viral carrier. Biomaterials 31(23):6075–6086. doi:10.1016/j.biomaterials.2010.04.042
Alivisatos AP (1996) Semiconductor clusters, nanocrystals, and quantum dots. Science 271(5251):933–937. doi:10.1126/science.271.5251.933
Gao J, Chen K, Xie R, Xie J, Yan Y, Cheng Z, Peng X, Chen X (2010) In vivo tumor-targeted fluorescence imaging using near-infrared non-cadmium quantum dots. Bioconjug Chem 21(4):604–609. doi:10.1021/bc900323v
Cai W, Chen K, Li ZB, Gambhir SS, Chen X (2007) Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. J Nucl Med 48(11):1862–1870. doi:10.2967/jnumed.107.043216
Chen O, Zhao J, Chauhan VP, Cui J, Wong C, Harris DK, Wei H, Han H-S, Fukumura D, Jain RK, Bawendi MG (2013) Compact high-quality CdSe–CdS core–shell nanocrystals with narrow emission linewidths and suppressed blinking. Nat Mater 12(5):445–451. doi:10.1038/nmat3539, http://www.nature.com/nmat/journal/v12/n5/abs/nmat3539.html#supplementary-information
Amelia M, Lincheneau C, Silvi S, Credi A (2012) Electrochemical properties of CdSe and CdTe quantum dots. Chem Soc Rev 41(17):5728–5743. doi:10.1039/C2CS35117J
Dabbousi BO, Rodriguez-Viejo J, Mikulec FV, Heine JR, Mattoussi H, Ober R, Jensen KF, Bawendi MG (1997) (CdSe)ZnS Core−shell quantum dots: synthesis and characterization of a size series of highly luminescent nanocrystallites. J Phys Chem B 101(46):9463–9475. doi:10.1021/jp971091y
Yuan J, Wen D, Gaponik N, Eychmüller A (2013) Enzyme-encapsulating quantum dot hydrogels and xerogels as biosensors: multifunctional platforms for both biocatalysis and fluorescent probing. Angew Chem Int Ed 52(3):976–979. doi:10.1002/anie.201205791
Wang J, Xia J (2011) Preferential binding of a novel polyhistidine peptide dendrimer ligand on quantum dots probed by capillary electrophoresis. Anal Chem 83(16):6323–6329. doi:10.1021/ac2011922
East DA, Mulvihill DP, Todd M, Bruce IJ (2011) QD-antibody conjugates via carbodiimide-mediated coupling: a detailed study of the variables involved and a possible new mechanism for the coupling reaction under basic aqueous conditions. Langmuir 27(22):13888–13896. doi:10.1021/la203273p
Algar WR, Krull UJ (2006) Adsorption and hybridization of oligonucleotides on mercaptoacetic acid-capped CdSe/ZnS quantum dots and quantum dot-oligonucleotide conjugates. Langmuir 22(26):11346–11352. doi:10.1021/la062217y
Algar WR, Tavares AJ, Krull UJ (2010) Beyond labels: a review of the application of quantum dots as integrated components of assays, bioprobes, and biosensors utilizing optical transduction. Anal Chim Acta 673(1):1–25. doi:10.1016/j.aca.2010.05.026
Belin T, Epron F (2005) Characterization methods of carbon nanotubes: a review. Mater Sci Eng: B 119(2):105–118. doi:10.1016/j.mseb.2005.02.046
Cheung W, Pontoriero F, Taratula O, Chen AM, He H (2010) DNA and carbon nanotubes as medicine. Adv Drug Deliv Rev 62(6):633–649. doi:10.1016/j.addr.2010.03.007
Pantarotto D, Singh R, McCarthy D, Erhardt M, Briand J-P, Prato M, Kostarelos K, Bianco A (2004) Functionalized carbon nanotubes for plasmid DNA gene delivery. Angew Chem Int Ed 43(39):5242–5246. doi:10.1002/anie.200460437
Singh R, Pantarotto D, McCarthy D, Chaloin O, Hoebeke J, Partidos CD, Briand JP, Prato M, Bianco A, Kostarelos K (2005) Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors. J Am Chem Soc 127(12):4388–4396. doi:10.1021/ja0441561
Bates K, Kostarelos K (2013) Carbon nanotubes as vectors for gene therapy: past achievements, present challenges and future goals. Adv Drug Deliv Rev 65(15):2023–2033. doi:10.1016/j.addr.2013.10.003
Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A 92(16):7297–7301
Wang X, Ren J, Qu X (2008) Targeted RNA interference of cyclin A2 mediated by functionalized single-walled carbon nanotubes induces proliferation arrest and apoptosis in chronic myelogenous leukemia K562 cells. ChemMedChem 3(6):940–945. doi:10.1002/cmdc.200700329
Podesta JE, Al‐Jamal KT, Herrero MA, Tian B, Ali‐Boucetta H, Hegde V, Bianco A, Prato M, Kostarelos K (2009) Antitumor activity and prolonged survival by carbon‐nanotube‐mediated therapeutic siRNA silencing in a human lung xenograft model. Small 5(10):1176–1185
Al-Jamal KT, Gherardini L, Bardi G, Nunes A, Guo C, Bussy C, Herrero MA, Bianco A, Prato M, Kostarelos K, Pizzorusso T (2011) Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing. Proc Natl Acad Sci 108(27):10952–10957. doi:10.1073/pnas.1100930108
Zheng M, Jagota A, Strano MS, Santos AP, Barone P, Chou SG, Diner BA, Dresselhaus MS, Mclean RS, Onoa GB (2003) Structure-based carbon nanotube sorting by sequence-dependent DNA assembly. Science 302(5650):1545–1548
Liu Z, Winters M, Holodniy M, Dai H (2007) siRNA delivery into human T cells and primary cells with carbon‐nanotube transporters. Angew Chem Int Ed 46(12):2023–2027
Dong H, Ding L, Yan F, Ji H, Ju H (2011) The use of polyethylenimine-grafted graphene nanoribbon for cellular delivery of locked nucleic acid modified molecular beacon for recognition of microRNA. Biomaterials 32(15):3875–3882
Gao H, Kong Y, Cui D, Ozkan CS (2003) Spontaneous insertion of DNA oligonucleotides into carbon nanotubes. Nano Lett 3(4):471–473
Lu Y, Liu J (2006) Functional DNA nanotechnology: emerging applications of DNAzymes and aptamers. Curr Opin Biotechnol 17(6):580–588
Cai D, Mataraza JM, Qin ZH, Huang Z, Huang J, Chiles TC, Carnahan D, Kempa K, Ren Z (2005) Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing. Nat Methods 2(6):449–454. doi:10.1038/nmeth761
Bartholomeusz G, Cherukuri P, Kingston J, Cognet L, Lemos R, Leeuw TK, Gumbiner-Russo L, Weisman RB, Powis G (2009) In vivo therapeutic silencing of hypoxia-inducible factor 1 alpha (HIF-1alpha) using single-walled carbon nanotubes noncovalently coated with siRNA. Nano Res 2(4):279–291. doi:10.1007/s12274-009-9026-7
Wang L, Shi J, Zhang H, Li H, Gao Y, Wang Z, Wang H, Li L, Zhang C, Chen C, Zhang Z, Zhang Y (2013) Synergistic anticancer effect of RNAi and photothermal therapy mediated by functionalized single-walled carbon nanotubes. Biomaterials 34(1):262–274. doi:10.1016/j.biomaterials.2012.09.037
Wang X, Wang X, Wang X, Chen F, Zhu K, Xu Q, Tang M (2013) Novel electrochemical biosensor based on functional composite nanofibers for sensitive detection of p53 tumor suppressor gene. Anal Chim Acta 765(0):63–69. doi:10.1016/j.aca.2012.12.037
Wang L, Wang X, Bhirde A, Cao J, Zeng Y, Huang X, Sun Y, Liu G, Chen X (2014) Carbon-dot-based two-photon visible nanocarriers for safe and highly efficient delivery of siRNA and DNA. Adv Healthcare Mater 3(8):1203–1209. doi:10.1002/adhm.201300611
Liu Y, Lou C, Yang H, Shi M, Miyoshi H (2011) Silica nanoparticles as promising drug/gene delivery carriers and fluorescent nano-probes: recent advances. Curr Cancer Drug Targets 11(2):156–163
Slowing II, Vivero-Escoto JL, Wu C-W, Lin VSY (2008) Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 60(11):1278–1288. doi:10.1016/j.addr.2008.03.012
Zhu S-G, Xiang J-J, Li X-L, Shen S-R, Lu H-b, Zhou J, Xiong W, Zhang B-C, Nie X-M, Zhou M, Tang K, Li G-Y (2004) Poly(l-lysine)-modified silica nanoparticles for the delivery of antisense oligonucleotides. Biotechnol Appl Biochem 39(2):179–187. doi:10.1042/BA20030077
Kar M, Vijayakumar PS, Prasad BLV, Gupta SS (2010) Synthesis and characterization of poly-l-lysine-grafted silica nanoparticles synthesized via NCA polymerization and click chemistry. Langmuir 26(8):5772–5781. doi:10.1021/la903595x
Chung TH, Wu SH, Yao M, Lu CW, Lin YS, Hung Y, Mou CY, Chen YC, Huang DM (2007) The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 28(19):2959–2966. doi:10.1016/j.biomaterials.2007.03.006
Kim JS, Yoon TJ, Yu KN, Noh MS, Woo M, Kim BG, Lee KH, Sohn BH, Park SB, Lee JK, Cho MH (2006) Cellular uptake of magnetic nanoparticle is mediated through energy-dependent endocytosis in A549 cells. J Vet Sci 7(4):321–326
He X, Li Y, He D, Wang K, Shangguan J, Shi H (2014) Aptamer-fluorescent silica nanoparticles bioconjugates based dual-color flow cytometry for specific detection of Staphylococcus aureus. J Biomed Nanotechnol 10(7):1359–1368
Park HS, Kim CW, Lee HJ, Choi JH, Lee SG, Yun YP, Kwon IC, Lee SJ, Jeong SY, Lee SC (2010) A mesoporous silica nanoparticle with charge-convertible pore walls for efficient intracellular protein delivery. Nanotechnology 21(22):225101. doi:10.1088/0957-4484/21/22/225101
Herranz F, Almarza E, Rodriguez I, Salinas B, Rosell Y, Desco M, Bulte JW, Ruiz-Cabello J (2011) The application of nanoparticles in gene therapy and magnetic resonance imaging. Microsc Res Tech 74(7):577–591. doi:10.1002/jemt.20992
Jung LS, Campbell CT, Chinowsky TM, Mar MN, Yee SS (1998) Quantitative interpretation of the response of surface plasmon resonance sensors to adsorbed films. Langmuir 14(19):5636–5648. doi:10.1021/la971228b
Kurihara K, Suzuki K (2002) Theoretical understanding of an absorption-based surface plasmon resonance sensor based on Kretchmann’s theory. Anal Chem 74(3):696–701
Lee SE, Sasaki DY, Perroud TD, Yoo D, Patel KD, Lee LP (2009) Biologically functional cationic phospholipid−gold nanoplasmonic carriers of RNA. J Am Chem Soc 131(39):14066–14074. doi:10.1021/ja904326j
Sperling RA, Rivera Gil P, Zhang F, Zanella M, Parak WJ (2008) Biological applications of gold nanoparticles. Chem Soc Rev 37(9):1896–1908. doi:10.1039/B712170A
Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM (2006) Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 79(939):248–253. doi:10.1259/bjr/13169882
Gosselin RE (1956) The uptake of radiocolloids by macrophages in vitro; a kinetic analysis with radioactive colloidal gold. J Gen Physiol 39(5):625–649
Warsi MF, Adams RW, Duckett SB, Chechik V (2010) Gd-functionalised Au nanoparticles as targeted contrast agents in MRI: relaxivity enhancement by polyelectrolyte coating. Chem Commun (Camb) 46(3):451–453. doi:10.1039/b915223g
Shevchenko EV, Bodnarchuk MI, Kovalenko MV, Talapin DV, Smith RK, Aloni S, Heiss W, Alivisatos AP (2008) Gold/iron oxide core/hollow-shell nanoparticles. Adv Mater 20(22):4323–4329. doi:10.1002/adma.200702994
Chen D-R, Wendt C, Pui DH (2000) A novel approach for introducing bio-materials into cells. J Nanopart Res 2(2):133–139. doi:10.1023/A:1010084032006
Yang NS, Burkholder J, Roberts B, Martinell B, McCabe D (1990) In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci 87(24):9568–9572
Daniel M-C, Astruc D (2004) Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 104(1):293–346
Bowman M-C, Ballard TE, Ackerson CJ, Feldheim DL, Margolis DM, Melander C (2008) Inhibition of HIV fusion with multivalent gold nanoparticles. J Am Chem Soc 130(22):6896–6897. doi:10.1021/ja710321g
Wang B, He X, Zhang Z, Zhao Y, Feng W (2012) Metabolism of nanomaterials in vivo: blood circulation and organ clearance. Acc Chem Res 46(3):761–769. doi:10.1021/ar2003336
Ghosh P, Han G, De M, Kim CK, Rotello VM (2008) Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 60(11):1307–1315
Govorov A, Zhang W, Skeini T, Richardson H, Lee J, Kotov N (2006) Gold nanoparticle ensembles as heaters and actuators: melting and collective plasmon resonances. Nanoscale Res Lett 1(1):84–90
Choi M-R, Stanton-Maxey KJ, Stanley JK, Levin CS, Bardhan R, Akin D, Badve S, Sturgis J, Robinson JP, Bashir R, Halas NJ, Clare SE (2007) A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. Nano Lett 7(12):3759–3765. doi:10.1021/nl072209h
Huff TB, Tong L, Zhao Y, Hansen MN, Cheng J-X, Wei A (2007) Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine 2(1):125–132
Hamad-Schifferli K, Schwartz JJ, Santos AT, Zhang S, Jacobson JM (2002) Remote electronic control of DNA hybridization through inductive coupling to an attached metal nanocrystal antenna. Nature 415(6868):152–155. http://www.nature.com/nature/journal/v415/n6868/suppinfo/415152a_S1.html
Acknowledgments
This work was supported by the College of Engineering and Mathematical Sciences at the University of Vermont, the Major State Basic Research Development Program of China (973 Program) (Grant Nos. 2014CB744503 and 2013CB733802), the National Natural Science Foundation of China (NSFC) (Grant Nos. 81422023, 81101101, 81371596, and 51273165), the Key Project of Chinese Ministry of Education (Grant No. 212149), the Fundamental Research Funds for the Central Universities, China (Grant No. 2013121039), and the Program for New Century Excellent Talents in University (NCET-13-0502).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media Singapore
About this chapter
Cite this chapter
Miao, T., Zhang, Y., Zeng, Y., Tian, R., Liu, G. (2016). Functional Nanoparticles for Molecular Imaging-Guided Gene Delivery and Therapy. In: Dai, Z. (eds) Advances in Nanotheranostics II. Springer Series in Biomaterials Science and Engineering, vol 7. Springer, Singapore. https://doi.org/10.1007/978-981-10-0063-8_8
Download citation
DOI: https://doi.org/10.1007/978-981-10-0063-8_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-0061-4
Online ISBN: 978-981-10-0063-8
eBook Packages: EngineeringEngineering (R0)